Revenue growth guidance of 25% for FY24
Management reiterated 25% revenue growth guidance for FY24, inclusive of both organic and inorganic contributions. May update later in the year based on M&A progress.
HAPPSTMNDS / guidance tracker
Keep management guidance in view.
Happiest Minds Technologies · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
EBITDA margin guidance of 20%-24%
EBITDA margin guidance maintained at 20%-24%, with Q1 delivering 25.5%. Wage hikes effective July may temporarily impact margins.
Setting up GenAI division with 100+ specialists
Establishing a dedicated GenAI division with an initial team of 100+ experts to drive use cases and solutions across domains.
Target of $1 billion revenue by FY31
Long-term goal of reaching $1 billion in revenue by FY31, with organic and inorganic growth contributing.
FY25 revenue growth of 30-35%
Management revised revenue growth guidance from 35-40% to 30-35% due to delayed closure of acquisitions, but remains confident of strong absolute growth.
EBITDA margin of 20-22% for FY25
EBITDA margin guidance maintained at 20-22% for the full year, with Q1 coming in at 23.9%.
Q2 margin headwinds from pay hikes and fewer working days
Annual pay increases effective July 1 will impact margins by 250-280 bps, and Q2 has fewer billing days, but management expects EBITDA to remain within the 20-22% band.
Billion-dollar revenue goal by FY31
Management reiterated long-term target of $1 billion revenue by FY31, supported by acquisitions and organic growth.
Double-digit constant currency growth for FY26
Management expects to deliver double-digit growth in constant currency for the full fiscal year, with H2 expected to be stronger than H1.
EBITDA margin maintained at 20-22%
EBITDA margin is guided to remain in the 20-22% range for FY26, despite wage hikes and continued investments.
GenAI business to reach same profitability as TDES by end of FY26 or early FY27
The GenAI business unit, which broke even at operating margin level in Q1, is expected to achieve profitability levels comparable to the TDES segment by year-end or early next year.
ARTA platform revenue growth of 20-25% in FY26
The flagship unified banking platform ARTA is expected to grow revenues by 20-25% in the current fiscal year.
FY24 organic revenue growth guidance revised to 12%
Management revised the full-year organic revenue growth guidance to 12% from a previous composite (organic+inorganic) target of 35%, citing a large acquisition that did not close and a cautious demand environment.
EBITDA margin guidance maintained at 22%-24%
The company retains its EBITDA margin guidance of 22%-24% for FY24.
GBS unit to generate meaningful revenue from next fiscal
The newly created Generative AI Business Services unit will not contribute meaningful revenue until the beginning of the next financial year.
Billion-dollar revenue target by FY31
The company reiterated its vision to achieve $1 billion in sales by FY 2031.
Revenue growth of 30-35% for FY25
Management reiterated full-year revenue growth guidance of 30-35%, expecting Q4 to be stronger than Q3 due to large deal closures.
EBITDA margin guidance of 20-22% for FY25
EBITDA margin is expected to remain in the 20-22% range for the full year, with Q3 impacted by fewer working days and leadership pay hikes.
Two large Arttha deals expected in H2
Management expects to close at least two large Arttha banking platform license deals in the next two quarters, with Q4 being the strongest.
New delivery center in Hyderabad operational in Q3
A new delivery center with 120-150+ seats in Hyderabad will become operational during Q3 FY25 to support capacity expansion.
Double-digit revenue growth commitment extended to four consecutive years through FY28
Management raised its commitment from three to four consecutive years of double-digit revenue growth in constant currency, through FY 2028.
EBITDA margin guidance maintained at 20%-22% for FY26
Management reiterated its aspiration to sustain EBITDA margins in the 20%-22% range for FY 2026.
GBS replicable solutions revenue potential of $15M over 3-4 years
22 replicable AI use cases in GBS represent a revenue potential of nearly $15 million over the next three to four years.
Net new logos expected to yield $50-60M over 3-4 years
The 30 new clients added in H1 are expected to generate $50-60 million in revenue over the next three to four years.
FY24 constant currency revenue growth guidance of 12%
Management reiterated the annual guidance of 12% YoY CC growth, implying a QoQ growth of ~4.5% in Q4.
EBITDA margin guidance of 22%-24%
Company has beaten this guidance for 15 consecutive quarters and expects to maintain within this range.
GenAI business unit to become significant growth engine next year
Management expects GenAI to be transformational from next year, with multiple POCs converting to orders.
FY25 constant currency revenue growth near 30%
Management aims to close FY25 with constant currency growth as close to 30% as possible, with Q4 expected to show strong sequential growth.
EBITDA margin guidance of 20-22% for FY25
Management expects to end FY25 with EBITDA margins within the guided range of 20-22%, with nine-month EBITDA margin at 22.1%.
Double-digit organic growth target for FY26
Management aims for double-digit organic growth in FY26, driven by GenAI, new sales engine, and verticalization.
GenAI POCs to convert to revenue in FY26
Approximately 15 GenAI proof-of-concept projects are expected to convert into significant orders and projects in the next fiscal year.
10%+ constant currency revenue growth for FY26
Management reaffirmed the commitment to deliver 10%+ revenue growth in constant currency for the current financial year.
EBITDA margin guidance of 20-22% for FY26
EBITDA margin is expected to remain in the 20-22% range for the current financial year.
Significant increase in growth guidance at Q4 results
Management expects to announce a significant increase in the growth guidance (above the 10% committed) when Q4 results are released.
Grow AI/Gen AI team to 1,000 by end of FY27
The company plans to scale its AI and Gen AI team to 1,000 employees by the end of FY2027.
FY25 revenue growth estimate of 35-40%
Management estimates FY25 revenue growth of 35-40%, including contributions from acquisitions and organic growth.
FY25 EBITDA margin guidance of 22-24%
EBITDA margin expected to be in the range of 22-24% for FY25, considering investments and acquisition integration.
GBS unit to grow to 250 people by end of FY25
The Generative AI business unit is expected to scale from 70 to 250 employees by the end of the fiscal year.
Target $1 billion revenue by 2031 at 22% CAGR
Management reaffirmed the vision to achieve $1 billion in revenue by 2031, requiring a 22% CAGR from FY25.
Healthy double-digit organic growth in FY26 and FY27
Management expects organic growth to remain in double digits for the next two years, driven by transformational initiatives.
EBITDA margin guidance of 20%-22% maintained
The company reiterated its EBITDA margin range of 20%-22% for the foreseeable future.
Healthcare product launch by Q1 FY27
A revolutionary healthcare product based on bioinformatics is expected to be available for launch by Q1 FY27, with cash-positive operations from the first year.
Integrated organizational structure announcement in 4-6 weeks
A new integrated structure combining Happiest Minds, PureSoftware, and Aureus will be announced within 4-6 weeks.